I 

113TH CONGRESS 

2D SESSION H. R. 5145 

To require breast density reporting to physicians and patients by facilities 

that perform mammograms, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

JULY 17, 2014 

Ms. DELAURO (for herself and Mr. ISRAEL) introduced the following bill; 

which was referred to the Committee on Energy and Commerce 

A BILL 

To require breast density reporting to physicians and patients by facilities that perform mammograms, and for 

other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Breast Density and 

5 Mammography Reporting Act of 2014’’. 

6 SEC. 2. FINDINGS. 

7 The Congress finds as follows: 

8 (1) The National Cancer Institute estimates 

9 that 1 in 8 women in the United States will develop 

10 a cancer of the breast in their lifetime. 


smartinez on DSK4TPTVN1PROD with BILLS
2 

•HR 5145 IH

1 (2) The Centers for Disease Control and Pre2 vention reports that breast cancer is the number one 

3 cause of cancer death among Hispanic women, and 

4 the number two cause of cancer death among White, 

5 Black, Asian/Pacific Islander, and American Indian/ 

6 Alaska Native women. 

7 (3) Individuals receiving mammograms are not 

8 currently required to receive medical summaries or 

9 reports from their mammogram providers which ad10 dress breast density or its correlation to masking the 

11 presence of breast cancer on mammograms, despite 

12 the fact that the radiologist interpreting the mam13 mogram makes an assessment of the patient’s breast 

14 density. 

15 SEC. 3. BREAST DENSITY REPORTING BY FACILITIES THAT 

16 PERFORM MAMMOGRAMS TO PHYSICIANS 

17 AND PATIENTS. 

18 (a) IN GENERAL.—Clause (ii) of section 354(f)(1)(G) 

19 of the Public Health Service Act (42 U.S.C. 

20 263b(f)(1)(G)) is amended— 

21 (1) in each of subclauses (III) and (IV), by 

22 striking ‘‘and’’ at the end; and 

23 (2) by adding at the end the following: 

24 ‘‘(V) the report under subclause (I) 

25 and the summary under subclause (IV) 


smartinez on DSK4TPTVN1PROD with BILLS
3 

•HR 5145 IH

1 shall include information about breast den2 sity, as specified by the Secretary based 

3 upon— 

4 ‘‘(aa) current scientific knowl5 edge; 

6 ‘‘(bb) technological advances; or 

7 ‘‘(cc) other updated medical pro8 cedures where the use of such screen9 ing developments is consistent with 

10 the practice of medical experts in the 

11 field; 

12 ‘‘(VI) the summary under subclause 

13 (IV) shall convey the effect of breast den14 sity in masking the presence of breast can15 cer on mammography, using the provider’s 

16 qualitative assessment of breast density; 

17 and 

18 ‘‘(VII) the summary under subclause 

19 (IV) shall include language, developed by 

20 the Secretary in consultation with leading 

21 experts and leading cancer organizations, 

22 communicating that individuals with dense 

23 breasts should talk with their physicians 

24 about— 


smartinez on DSK4TPTVN1PROD with BILLS
4 

•HR 5145 IH

1 ‘‘(aa) any questions or concerns 

2 regarding the summary; and 

3 ‘‘(bb) whether the individuals 

4 would benefit from additional tests.’’. 

5 (b) RULE OF CONSTRUCTION.—This section and the 

6 amendments made by this section shall not be construed 

7 to alter in any way Federal requirements relating to finan8 cial obligations of any person in connection with health 

9 insurance. 

10 SEC. 4. ENHANCING RESEARCH RELATING TO BREAST DEN11 SITY. 

12 Title III of the Public Health Service Act is amended 

13 by inserting after section 354 of such Act (42 U.S.C. 

14 263b) the following: 

15 ‘‘SEC. 354A. ENHANCING RESEARCH RELATING TO BREAST 

16 DENSITY. 

17 ‘‘The Secretary shall expand and intensify the pro18 grams and activities of the Department of Health and 

19 Human Services for conducting or supporting— 

20 ‘‘(1) applied research on breast density; 

21 ‘‘(2) research on the cost-effectiveness, effec22 tiveness, and feasibility of reimbursement models for 

23 supplemental imaging relating to breast density; and 

24 ‘‘(3) research in support of clinical guidelines 

25 and best practices concerning use of mammograms 


smartinez on DSK4TPTVN1PROD with BILLS
5 

•HR 5145 IH

1 and supplemental screening for women with dense 

2 breasts.’’. 

Æ 


smartinez on DSK4TPTVN1PROD with BILLS